U.S. Markets closed

Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics

Ron Leuty
Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics

Why a South Bay company thinks it can disrupt a tough antibiotics market — and more in our weekly Health Care Digest.